Mihajlo Jakovljevic
Liang Wang
Chiranjivi Adhikari- 1Institute of Advanced Manufacturing Technologies, Peter the Great St. Petersburg Polytechnic University, Saint Petersburg, Russia
- 2Institute of Comparative Economic Studies, Hosei University, Tokyo, Japan
- 3Department of Global Health Economics and Policy, University of Kragujevac, Kragujevac, Serbia
- 4Department of Public Health, Robbins College of Health and Human Sciences, Baylor University Waco, TX, United States
- 5Indian Institute of Public Health Gandhinagar (IIPHG), Gandhinagar, India
- 6Department of Public Health, School of Health and Allied Sciences (SHAS), Pokhara University, Pokhara, Nepal
Editorial on the Research Topic
Asian health sectors growth in the next decade—Optimism despite challenges ahead
The Western Pacific and the Southeast WHO regions of Asia have a variety of economies, from middle-income India, Laos, and Myanmar to high-income OECD countries, such as Japan and South Korea. These regions are home to a sizable population and act as an epicenter of global manufacturing and industrial capacity (1).
While most of Asia was under colonial rule before World War II, it became the fastest-growing economic region of the world in recent decades, manifesting some of the world's longest economic booms, starting from Japan in the 1950s, to South Korea, China, and recently to India and the Tiger Cub Economies, such as Singapore and Malaysia (2). In contrast, these boomed economies later faced setbacks due to various reasons, such as the 1997 Asian financial crisis, which spread to the ASEAN (Association of South East Asian Nations) region (3), the contraction of the GDP in countries such as Indonesia and Sri Lanka, the aftermath of the heavy inflow of foreign aid that was demanded following a tsunami and other disastrous natural calamities (4), the impact of the 2008–2009 global recession and its effects in Asian countries (5), and the recent COVID-19 pandemic. These caused multi-faceted economic effects in Central Asia (6), and other Asian countries.
In addition to these ups and downs, a meager proportion (approximately 4–7%) of total GDP has been invested in the health sector in most Asian countries, in comparison to approximately 12% or more of that in European countries, the United States, and other high-income countries. Increased health awareness leading to increased health demand has, directly and indirectly, pressurized the ruling governments in the region to invest in the health sector, leading to multiple and mixed avenues of different opportunities and challenges for health sector growth.
Of the total 17 manuscripts accepted for this Research Topic, 14 are original research papers, two are reviews, and one is a perspective article. The manuscripts and total numbers are found under the following six themes: Primary Health Care (PHC) and Health Systems Development (HSD) (four manuscripts); (Health) insurance, governance, and universal health coverage (UHC) (four manuscripts); public health screening (two manuscripts); urban and green economics, and sustainability (two manuscripts); health care profession, ethics, and leadership (three manuscripts); and health tourism and migrants' health (two manuscripts). Geographic coverage is as follows: seven and two manuscripts are from China and Nepal, respectively, and one each represents Asia, the Middle East and North Africa (MENA), Mongolia, Malaysia, South Korea, Japan, and Indonesia (Table 1).
Table 1. Scopes and summary findings of the studies.
The editors observed that shifting infrastructure development to less developed regions, focusing on women's empowerment, and guiding the referral system may enhance access to PHC and thereby advance health and social development (HSD); for which the non-state actors should work in close collaboration with the state. In order to achieve UHC, the health sector in the next decade is expected to grow and move beyond HSD. For this, in addition to financial and non-financial barriers to health insurance, alternative strategies to existing insurance schemes are crucial, including social health insurance (HI), as some Asian and African countries are moving closer to UHC by HI reforms (7, 8); improved governance through localized employees; public health screening with cost-effective tools and strategies, such as portable ECGs and the gastric cancer risk score scale (GCRSS), which can be further captivated with the Health Technology Assessment (HTA) (9) and may further help in reducing the ongoing catastrophic expenditures of households with noncommunicable diseases (NCDs) (10); and the leadership skills and training of health care professionals. Another area of growth in the health sector is health tourism, for which patient satisfaction and enhancing the trust between the health professionals and the patient are warranted. Since domestic manufacturing is not meeting the ever-rising demand for medical services, which is visible in terms of more significant health and pharmaceutical expenditures (11) on equipment and medicines (12), cross-country health and medical tourism is inevitable. To meet this demand and intra-country unmet healthcare challenges in some countries while also seizing other markets, institutions should consider other informed solutions to solve conflicting interests between the pharma company and the health sector. Furthermore, economic resilience after the COVID-19 pandemic and maintaining the pro-green economies may contribute to the region's health sector growth and to its sustainability, including the ability to face challenges to meet sustainable development goals (13).
Conclusive remarks
The editors believe these valuable and diverse topic contributions might open new horizons of knowledge. Last but not least this is a unique opportunity to open the floor for a public debate on the Asian challenges through the lens of the Global South's health sector growth (12). The main goal of this Research Topic was to describe the progress made in the healthcare arena in Asian Emerging economies. A diverse group of authors coming from academia, industry, governing authorities, and professional associations attempted to provide a thorough overview of the status of the healthcare sector growth in Asian-Pacific economies (14). We hope that this collection of articles can trigger curiosity among aspiring Asian public health authorities, HTA experts, clinical physicians, economists, and public communities alike.
Author contributions
MJ and CA prepared the manuscript draft while MJ, CA, and LW revised it for important intellectual content. All authors fulfill ICMJE conditions for full authorship. All authors contributed to the article and approved the submitted version.
Funding
The Serbian part of this contribution has been co-financed through Grant No. OI 175014 of the Ministry of Education Science and Technological Development of the Republic of Serbia.
Acknowledgments
We are thankful to the Ministry of Education Science and Technological Development of the Republic of Serbia for the grant. We also duly thank all the authors for their contributions.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1. Jakovljevic M, Sugahara T, Timofeyev Y, Rancic N. Predictors of (in) efficiencies of healthcare expenditure among the leading asian economies–comparison of OECD and non-OECD nations. Risk Manag Healthc Policy. (2020) 13:2261. doi: 10.2147/RMHP.S266386
2. Wikipedia. (2023). Economy of Asia. Available online at: https://en.wikipedia.org/wiki/Economy_of_Asia (accessed January 20, 2023).
3. Elangkovan K, Said MHM. The Asian Financial Crisis 1997-1998 and Malaysian response: an analytical approach. Austr J Basic Appl Sci. (2013) 7:622–33. Available online at: https://www.researchgate.net/publication/261079500_Manager_Perception (accessed January 10, 2021).
4. Jayasuriya S, McCawley P. Reconstruction after a major disaster: lessons from the post-tsunami experience in Indonesia, Sri Lanka, and Thailand. ADBI Working Paper. (2008).
5. Briguglio L, Piccinino S. Growth with resilience in East Asia and the 2008–2009 global recession. Asian Develop Rev. (2012) 29:183–206. doi: 10.2139/ssrn.2204797
7. Lagomarsino G, Garabrant A, Adyas A, Muga R, Otoo N. Moving towards universal health coverage: health insurance reforms in nine developing countries in Africa and Asia. Lancet. (2012) 380:933–43. doi: 10.1016/S0140-6736(12)61147-7
8. Mallapaty S. China's five-year plan focuses on scientific self-reliance. Nature. (2021) 591:353–5. doi: 10.1038/d41586-021-00638-3
9. Adhikari C, Dhakal R, Adhikari LM, Parajuli B, Subedi KR, Aryal Y, et al. Need for HTA supported risk factor screening for hypertension and diabetes in Nepal: A systematic scoping review. Front Cardiov Med. (2022) 9:898225. doi: 10.3389/fcvm.2022.898225
10. Jakovljevic M, Jakab M, Gerdtham U, McDaid D, Ogura S, Varavikova E, et al. Comparative financing analysis and political economy of noncommunicable diseases. J Med Econ. (2019) 22:722–7. doi: 10.1080/13696998.2019.1600523
11. Jakovljevic M, Wu W, Merrick J, Cerda A, Varjacic M, Sugahara T. Asian innovation in pharmaceutical and medical device industry–beyond tomorrow. J Med Econ. (2021) 24:42–50. doi: 10.1080/13696998.2021.2013675
12. Jakovljevic M, Liu Y, Cerda A, Simonyan M, Correia T, Mariita RM, et al. The Global South political economy of health financing and spending landscape–history and presence. J Med Econ. (2021) 24:25–33. doi: 10.1080/13696998.2021.2007691
13. Sapkota B, Palaian S, Shrestha S, Ozaki A, Mohamed Ibrahim MI, Jakovljevic M. Gap analysis in manufacturing, innovation and marketing of medical devices in the Asia-Pacific region. Expert Rev Pharmacoecon Out Res. (2022) 22:1043–50. doi: 10.1080/14737167.2022.2086122
Keywords: Asia-Pacific, China, Japan, universal health coverage (UHC), health expenditure, developing countries, health care cost, medical care
Citation: Jakovljevic M, Wang L and Adhikari C (2023) Editorial: Asian health sector growth in the next decade—Optimism despite challenges ahead. Front. Public Health 11:1150917. doi: 10.3389/fpubh.2023.1150917
Received: 25 January 2023; Accepted: 31 January 2023;
Published: 20 February 2023.
Edited and reviewed by: Hai Fang, Peking University, China
Copyright © 2023 Jakovljevic, Wang and Adhikari. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Mihajlo Jakovljevic, 
sidartagothama@gmail.com; Chiranjivi Adhikari, chiranadhikari@gmail.com